PT Archi Indonesia Tbk (IDX:ARCI)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,998,775	6,159,080	10,132,680	8,245,220	14,031,775	-
Market Cap Growth	-25.58%	-39.22%	22.89%	-41.24%	-	-
Enterprise Value	25,498,395	12,215,722	16,140,154	12,873,096	18,098,462	-
Last Close Price	765.00	248.00	408.00	332.00	565.00	-
PE Ratio	26.40	36.59	45.12	36.49	13.10	-
Forward PE	-	11.36	11.36	11.36	8.61	-
PS Ratio	3.47	1.33	2.63	2.45	2.85	-
PB Ratio	3.80	1.40	2.50	2.14	4.23	-
P/TBV Ratio	3.80	1.40	2.50	2.14	4.23	-
P/FCF Ratio	-	-	-	-	163.82	-
P/OCF Ratio	13.88	4.25	30.98	9.78	7.93	-
EV/Sales Ratio	4.66	2.64	4.20	3.83	3.67	-
EV/EBITDA Ratio	11.65	10.28	12.82	10.63	7.85	-
EV/EBIT Ratio	13.79	14.41	18.67	19.95	9.43	-
EV/FCF Ratio	-346.09	-	-	-	211.30	-
Debt / Equity Ratio	1.42	1.48	1.54	1.26	1.31	4.21
Debt / EBITDA Ratio	4.27	5.48	4.96	4.01	1.88	1.64
Debt / FCF Ratio	157.30	-	-	-	50.54	5.67
Asset Turnover	0.38	0.35	0.33	0.31	0.54	0.65
Inventory Turnover	4.04	3.83	3.22	3.30	4.98	4.78
Quick Ratio	0.08	0.15	0.23	0.15	0.13	0.43
Current Ratio	0.40	0.50	0.77	0.43	0.39	0.81
Return on Equity (ROE)	9.26%	3.89%	5.78%	6.05%	45.92%	91.99%
Return on Assets (ROA)	5.42%	3.94%	4.61%	3.69%	13.05%	22.59%
Return on Capital (ROIC)	6.80%	4.89%	5.71%	4.74%	16.38%	27.28%
Return on Capital Employed (ROCE)	10.90%	7.70%	8.20%	8.00%	27.60%	46.30%
Earnings Yield	4.21%	2.73%	2.22%	2.74%	7.63%	-
FCF Yield	-0.39%	-0.45%	-15.38%	-2.83%	0.61%	-
Payout Ratio	-	-	-	-	-	163.91%
Buyback Yield / Dilution	-	-	-	-2.54%	-2.66%	-
Total Shareholder Return	-	-	-	-2.54%	-2.66%	-

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.